GE Healthcare has announced a new $100 million contract with a European imaging company and new investments in 3D printing, robotics and virtual patient monitoring.

CVS Health is acquiring Centene’s Illinois health plan subsidiary, IlliniCare Health Plan, the companies announced Dec. 2. Financial terms of the transaction were not disclosed.

 

Medical care costs are set to rise again in 2020, with a projected increased of 6.8%, according to the 2020 Global Medical Trends Survey Report from Willis Towers Watson.

 

Hospitals were overpaid by roughly $502 million from 2011 to 2014, according to a report from the Office of Inspector General (OIG), which blamed the overpayment on CMS limitations on the reconciliation period.

A major industry group representing pharmaceutical companies has ceased funding to a nonprofit group that aims to help people addicted to opioids, Politico reported.

Hospitals provided about $12.8 million on average in uncompensated care in 2018, according to a new report from Definitive Healthcare.

Patient outcomes don’t differ significantly across high- or low-cost hospitals, according to a study from Harvard and Yale researchers published in JAMA Network Open.

Humana has released the findings of its latest value-based care report, detailing how the company is continuing to move away from fee-for-service when it comes to their Medicare Advantage population.

Walgreens has opened up the first in-store primary care clinic with VillageMD, a primary care company based in Chicago that operates nationally. The clinic, based in Houston, is one of five planned sites of care in the city.

Medication in the U.S. is the most expensive in the world, costing 307% more than the global median, according to a recent study on medication costs around the world.

Health systems are looking to boost patient engagement and invest more in data and analytics in 2020, according to a new report looking at the top initiatives for next year. 

A new drug with the potential to help heart-failure patients comes with a staggering cost––$651 a day, or $225,000 a year. The sky-high price tag has caused some researchers associated with developing the drug to speak out, Bloomberg reported.